Fig. 1From: A new insight into the role of plasma fibrinogen in the development of metabolic syndrome from a prospective cohort study in urban Han Chinese populationThe incidence of MetS by quartiles of fibrinogen in whole participants (a) and in overweight (b), dyslipidemia (c), hypertension (d), and hyperglycemia (e) sub-cohorts in male and female. In whole participants (a), 853 of 3843 males and 322 of 2366 females developed MetS during follow-up; In overweight sub-cohort (b), 618 of 1952 males and 198 of 717 females developed MetS during follow-up; In dyslipidemia sub-cohort (c), 344 of 1313 males and 100 of 483 females developed MetS during follow-up; In hypertension sub-cohort (d), 332 of 961 males and 163 of 511 females developed MetS during follow-up; In hyperglycemia sub-cohort (e), 96 of 251 males and of 115 females developed MetS during follow-upBack to article page